Farther Finance Advisors, LLC Novo Cure LTD Transaction History
Farther Finance Advisors, LLC
- $2.67 Trillion
- Q3 2024
A detailed history of Farther Finance Advisors, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 146 shares of NVCR stock, worth $4,657. This represents 0.0% of its overall portfolio holdings.
Number of Shares
146
Previous 129
13.18%
Holding current value
$4,657
Previous $2.24 Million
1.97%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NVCR
# of Institutions
263Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$387 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$378 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$253 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$137 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$96.7 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $3.35B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...